High Altitude Pulmonary Edema and Hypothermia Clinical Features Diagnosis and Management
medicine

High Altitude Pulmonary Edema and Hypothermia Clinical Features Diagnosis and Management


HIGH-ALTITUDE PULMONARY EDEMA (HAPE)

1. Definition

High-Altitude Pulmonary Edema (HAPE) is a life-threatening, non-cardiogenic pulmonary edema that occurs due to hypoxia-induced pulmonary hypertension after rapid ascent to high altitude, usually >2,500–3,000 m.


2. Pathophysiology

  • Hypobaric hypoxia → uneven hypoxic pulmonary vasoconstriction
  • Over-perfusion of some capillary beds → capillary stress failure
  • Leakage of protein-rich fluid into alveoli
  • No left ventricular dysfunction (normal PCWP)
  • Reduced nitric oxide, increased endothelin-1
  • Genetic susceptibility (↓ HIF response)

3. Risk Factors / Triggers

  • Rapid ascent
  • No acclimatization
  • Prior history of HAPE
  • Cold exposure
  • Heavy exertion
  • Respiratory infection
  • Male sex
  • Use of sedatives or alcohol

4. Clinical Features

Early Symptoms

  • Reduced exercise tolerance
  • Dry cough
  • Dyspnea on exertion
  • Fatigue

Progressive / Severe Features

  • Dyspnea at rest
  • Orthopnea
  • Pink frothy sputum
  • Chest tightness
  • Cyanosis
  • Tachycardia, tachypnea
  • Low-grade fever (misleading)

Examination

  • Crackles (often right middle/lower lobe first)
  • Wheeze
  • Hypoxia disproportionate to exam

5. Investigations

At Altitude (Clinical Diagnosis)

  • SpO₂ markedly reduced
  • Chest auscultation: crackles
  • Portable CXR (if available): patchy perihilar opacities

Hospital

  • Chest X-ray: bilateral patchy infiltrates, normal heart size
  • ABG: hypoxemia ± respiratory alkalosis
  • Echocardiography: elevated pulmonary artery pressure, normal LV
  • BNP: normal or mildly elevated

6. Differential Diagnosis

  • Pneumonia
  • Pulmonary embolism
  • Acute mountain sickness (AMS)
  • High-altitude cerebral edema (HACE)
  • Cardiogenic pulmonary edema
  • ARDS

7. Management (Stepwise)

Immediate (Life-Saving)

  1. Immediate descent (≥1,000 m) → MOST IMPORTANT
  2. High-flow oxygen (target SpO₂ >90%)
  3. Rest and warmth

Pharmacologic Management

A. Nifedipine

  • Indication: Moderate–severe HAPE, prevention in high-risk
  • Mechanism: Pulmonary vasodilation → ↓ pulmonary artery pressure
  • Dose:

* Adult: 30 mg SR PO every 12 hours

  • Adverse Effects: Hypotension, headache, flushing
  • Contraindications: Hypotension
  • Monitoring: BP
  • Counseling: Rise slowly, avoid dehydration

B. Phosphodiesterase-5 Inhibitors (Adjunct)

  • Sildenafil: 50 mg PO every 8 hours
  • Tadalafil: 10 mg PO twice daily
  • MOA: ↑ NO-mediated vasodilation
  • Avoid with nitrates

C. Dexamethasone (If HACE overlap)

  • 8 mg loading → 4 mg every 6 hours

Non-Pharmacologic

  • Portable hyperbaric chamber (Gamow bag)
  • Avoid exertion
  • Avoid alcohol/sedatives

8. Prevention

  • Gradual ascent (<300–500 m/day above 3,000 m)
  • Rest days every 1,000 m
  • Nifedipine prophylaxis in prior HAPE
  • Avoid cold exposure
  • Adequate hydration

9. Prognosis

  • Excellent with early descent
  • Fatal if untreated
  • High recurrence risk without prevention


HYPOTHERMIA

1. Definition

Hypothermia is a condition where core body temperature <35°C (95°F) due to failure of thermoregulation.


2. Classification

| Severity | Core Temperature |

| -------- | ---------------- |

| Mild | 32–35°C |

| Moderate | 28–32°C |

| Severe | <28°C |


3. Pathophysiology

  • Heat loss > heat production
  • Peripheral vasoconstriction → heat conservation
  • ↓ Enzyme activity
  • Cardiac electrical instability
  • Coagulopathy
  • Cold diuresis → hypovolemia

4. Causes

Environmental

  • Cold exposure
  • Immersion in cold water
  • High altitude

Medical

  • Sepsis
  • Hypothyroidism
  • Adrenal insufficiency
  • Malnutrition

Drugs

  • Alcohol
  • Sedatives
  • Antipsychotics
  • Opioids

5. Clinical Features

Mild (32–35°C)

  • Shivering
  • Tachycardia
  • Slurred speech
  • Ataxia

Moderate (28–32°C)

  • Cessation of shivering
  • Bradycardia
  • Hypotension
  • Altered sensorium

Severe (<28°C)

  • Coma
  • Ventricular arrhythmias
  • Apnea
  • Fixed pupils (can be reversible)

6. Investigations

  • Core temperature (esophageal, rectal, bladder)
  • ECG: Osborn (J) waves, prolonged PR/QT
  • ABG: metabolic acidosis
  • Electrolytes (hypokalemia initially)
  • Coagulation profile
  • Glucose (hypoglycemia common)

7. Differential Diagnosis

  • Stroke
  • Drug overdose
  • Sepsis
  • Hypoglycemia
  • Myxedema coma

8. Management (Stepwise)

General Principles

  • Handle gently (prevent arrhythmias)
  • ABC stabilization
  • Treat hypoglycemia
  • “No one is dead until warm and dead”

A. Passive Rewarming (Mild)

  • Remove wet clothes
  • Insulation
  • Warm environment
  • Oral warm fluids (if conscious)

B. Active External Rewarming (Moderate)

  • Forced warm air blankets
  • Heating pads to trunk (not limbs)
  • Warm IV fluids (38–42°C)

C. Active Internal Rewarming (Severe)

  • Warm IV fluids
  • Warm humidified oxygen
  • Gastric, bladder, peritoneal lavage
  • ECMO / cardiopulmonary bypass (gold standard if cardiac arrest)

9. Cardiac Arrest in Hypothermia

  • Prolonged CPR allowed
  • Defibrillation ≤3 attempts until temp >30°C
  • Medications withheld or spaced widely <30°C

10. Complications

  • Ventricular fibrillation
  • Coagulopathy
  • Rhabdomyolysis
  • Acute kidney injury
  • Aspiration pneumonia

11. Prognosis

  • Excellent with timely rewarming
  • Children and cold-water immersion have better outcomes
  • Survival reported at core temps as low as 13.7°C

12. Key Exam Pearls

  • HAPE = descent + oxygen
  • Hypothermia = gentle handling
  • Shivering stops at ~30°C
  • Osborn waves are characteristic
  • Do not declare death until rewarmed

Interactive MCQ Quiz

MCQ Exam Mode

15 Questions
Question 1 of 15

Frequently Asked Questions

High altitude pulmonary edema is a life-threatening non-cardiogenic pulmonary edema caused by hypoxia-induced pulmonary hypertension after rapid ascent to high altitude, usually above 2500 to 3000 meters.
It is caused by uneven hypoxic pulmonary vasoconstriction leading to high pulmonary artery pressure, capillary stress failure, and leakage of protein-rich fluid into the alveoli.
Early symptoms include reduced exercise tolerance, exertional dyspnea, dry cough, fatigue, and mild chest tightness.
Severe signs include dyspnea at rest, orthopnea, pink frothy sputum, cyanosis, tachycardia, hypoxemia, and bilateral lung crackles.
Diagnosis is primarily clinical based on symptoms, hypoxemia, chest findings, and history of recent ascent, supported by chest X-ray showing patchy bilateral infiltrates with normal heart size.
Immediate descent to a lower altitude combined with supplemental oxygen is the most critical and life-saving treatment.
Nifedipine is the primary drug used; phosphodiesterase-5 inhibitors like sildenafil may be used, and dexamethasone is added if cerebral edema is suspected.
Prevention includes gradual ascent, adequate acclimatization, avoiding strenuous exertion, keeping warm, and prophylactic nifedipine in individuals with prior HAPE.
Hypothermia is a condition in which core body temperature falls below 35 degrees Celsius due to excessive heat loss or impaired thermoregulation.
Hypothermia is classified as mild at 32 to 35 degrees Celsius, moderate at 28 to 32 degrees Celsius, and severe below 28 degrees Celsius.
Common causes include environmental cold exposure, immersion in cold water, high altitude exposure, alcohol or sedative use, sepsis, hypothyroidism, and malnutrition.
Mild hypothermia presents with shivering, tachycardia, slurred speech, impaired coordination, and cold diuresis.
Osborn or J waves on ECG are characteristic of hypothermia and indicate increased risk of ventricular arrhythmias.
Management includes gentle handling, airway and circulation support, correction of hypoglycemia, and rewarming using passive, active external, or active internal methods depending on severity.
The key principle is that no one is considered dead until warm and dead, as hypothermia can mimic death and patients may recover after rewarming.